| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Lease impairment charges | NaN | 0 | 779 | 0 |
| Net loss | -1,525 | -5,103 | 7,825 | -1,489 |
| Stock-based compensation | 11,889 | 10,548 | 10,260 | 20,732 |
| Depreciation expense and amortization of intangible assets | 2,273 | 2,277 | 2,459 | 4,970 |
| Bad debt expense | -194 | 540 | 142 | 550 |
| Amortization of debt issuance costs | 150 | 150 | 150 | 300 |
| Benefit for deferred income taxes | -74 | 299 | 41 | -689 |
| Foreign currency transaction losses (gains), net | -1,119 | 868 | 205 | 20,659 |
| Accounts receivable | -81,353 | 81,328 | 20,065 | -49,720 |
| Prepaid expenses and other assets | -1,333 | -2,037 | -3,105 | -10,174 |
| Deferred commissions | 707 | -6,839 | 416 | 3,228 |
| Accounts payable and accrued expenses | 637 | -3,602 | 5,312 | 7,559 |
| Accrued compensation and related benefits | 25,569 | -21,036 | -2,768 | 3,811 |
| Other current and non-current liabilities | -468 | -1,782 | -1,430 | -277 |
| Deferred revenue | -21,799 | 64,745 | 8,066 | -25,611 |
| Operating lease assets and liabilities, net | -1,005 | -973 | -912 | -1,671 |
| Net cash provided by operating activities | 48,827 | 1,137 | 18,711 | 43,026 |
| Proceeds from maturities of investments | 39,771 | 18,262 | 6,293 | 27,985 |
| Purchases of investments | 44,866 | 2,767 | 0 | 59,281 |
| Purchases of property and equipment | 188 | 867 | 654 | 1,797 |
| Net cash used by investing activities | -5,283 | 14,628 | 5,639 | -33,093 |
| Proceeds from borrowings | NaN | 0 | 0 | 0 |
| Payments for debt issuance costs | NaN | 0 | 0 | 0 |
| Debt repayments | 2,500 | 5,000 | 0 | 5,000 |
| Repurchases of common stock | 21,808 | 0 | 10,000 | 10,000 |
| Payments for employee taxes related to the net share settlement of equity awards | 5,117 | 1,506 | 1,421 | 4,469 |
| Proceeds from exercise of common stock options | 630 | 366 | 248 | 504 |
| Net cash used by financing activities | -28,795 | -6,140 | -11,173 | -18,965 |
| Effect of foreign exchange rate changes on cash and cash equivalents | -534 | 936 | -135 | 2,687 |
| Net increase in cash and cash equivalents | 14,215 | 10,561 | 13,042 | -6,345 |
| Cash and cash equivalents at beginning of period | 135,810 | 125,249 | 118,552 | NaN |
| Cash and cash equivalents at end of period | 150,025 | 135,810 | 125,249 | NaN |
APPIAN CORP (APPN)
APPIAN CORP (APPN)